{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:46:28Z","timestamp":1785296788427,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.hrthm.2023.11.012","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:02:31Z","timestamp":1705276951000},"page":"329-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The real-world incidence of severe QT prolongation in patients taking antipsychotic drugs"],"prefix":"10.1016","volume":"21","author":[{"given":"Clifford","family":"TeBay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3859-3716","authenticated-orcid":false,"given":"Jamie I.","family":"Vandenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2023.11.012_bib1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2023.11.012_bib2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","article-title":"hERG K+ channels: structure, function, and clinical significance","volume":"92","author":"Vandenberg","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.hrthm.2023.11.012_bib3","series-title":"Guidance for industry: S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals","year":"2005"},{"key":"10.1016\/j.hrthm.2023.11.012_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2023.11.012_bib5","doi-asserted-by":"crossref","first-page":"K70","DOI":"10.1016\/S1520-765X(01)90009-4","article-title":"Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes","volume":"3","author":"Darp\u00f6","year":"2001","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.hrthm.2023.11.012_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/IJCIIS.IJCIIS_59_17","article-title":"Prevalence and prognostic significance of prolonged QTc interval in emergency medical patients: a prospective observational study","volume":"8","author":"Birda","year":"2018","journal-title":"Int J Crit Illn Inj Sci"},{"key":"10.1016\/j.hrthm.2023.11.012_bib7","first-page":"3","article-title":"Hospitalized cancer patients with acquired long QT syndrome\u2014a matched case-control study","volume":"6","author":"Lin","year":"2020","journal-title":"Cardiooncology"},{"key":"10.1016\/j.hrthm.2023.11.012_bib8","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.hrthm.2017.03.014","article-title":"Acquired long QT syndrome in hospitalized patients","volume":"14","author":"Yu","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2023.11.012_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.hrthm.2023.10.027","article-title":"Incidences, risk factors, and clinical correlates of severe QT prolongation after the use of quetiapine or haloperidol","volume":"21","author":"Wang","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2023.11.012_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0002-8703(96)90525-6","article-title":"Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability","volume":"131","author":"Pratt","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2023.11.012_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0167-5273(01)00485-5","article-title":"QT interval effects of cisapride in the clinical setting","volume":"80","author":"Wang","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2023.11.012_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12551-022-00929-7","article-title":"Metabolic and electrolyte abnormalities as risk factors in drug-induced long QT syndrome","volume":"14","author":"TeBay","year":"2022","journal-title":"Biophys Rev"},{"key":"10.1016\/j.hrthm.2023.11.012_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2017.11.029","article-title":"Effects of norquetiapine, the active metabolite of quetiapine, on cloned hERG potassium channels","volume":"664","author":"Lee","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.hrthm.2023.11.012_bib14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.bjp.0700989","article-title":"The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes","volume":"120","author":"Suessbrich","year":"1997","journal-title":"Br J Pharmacol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527123029156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527123029156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:59:57Z","timestamp":1761548397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527123029156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1547527123029156"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2023.11.012","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The real-world incidence of severe QT prolongation in patients taking antipsychotic drugs","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2023.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2023.10.027","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}